Back to Search Start Over

Adenylate cyclase 1 knockdown attenuates pirarubicin-induced cardiotoxicity.

Authors :
Zhang W
Shu Z
Huang P
Cheng H
Ji J
Wei D
Ren L
Source :
Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2024 Oct; Vol. 51 (10), pp. e13920.
Publication Year :
2024

Abstract

This study aimed to investigate the effects and possible mechanisms of adenylate cyclase 1 (ADCY1) on pirarubicin-induced cardiomyocyte injury. HL-1 cells were treated with pirarubicin (THP) to induce intracellular toxicity, and the extent of damage to mouse cardiomyocytes was assessed using CCK-8, Edu, flow cytometry, ROS, ELISA, RT-qPCR and western blotting. THP treatment reduced the viability of HL-1 cells, inhibited proliferation, induced apoptosis and triggered oxidative stress. In addition, the RT-qPCR results revealed that ADCY1 expression was significantly elevated in HL-1 cells, and molecular docking showed a direct interaction between ADCY1 and THP. Western blotting showed that ADCY1, phospho-protein kinase A and GRIN2D expression were also significantly elevated. Knockdown of ADCY1 attenuated THP-induced cardiotoxicity, possibly by regulating the ADCY1/PKA/GRIN2D pathway.<br /> (© 2024 John Wiley & Sons Australia, Ltd.)

Details

Language :
English
ISSN :
1440-1681
Volume :
51
Issue :
10
Database :
MEDLINE
Journal :
Clinical and experimental pharmacology & physiology
Publication Type :
Academic Journal
Accession number :
39227014
Full Text :
https://doi.org/10.1111/1440-1681.13920